ORX:STO
Orexo AB
1,37 SEK
arrow_downward
-1,58%(-0,022) 1D
6 қар., 17:29:49 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,47 SEK
High
1,47 SEK
Low
1,31 SEK
Mkt. cap
48,05 млн
Avg. vol.
320,60 м.
Volume
525,28 м.
P/E ratio
0,06
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,47 SEK
High
1,47 SEK
Low
1,31 SEK
Mkt. cap
48,05 млн
Avg. vol.
320,60 м.
Volume
525,28 м.
P/E ratio
0,06
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
Yahoo Finance
·
22 сағат бұрын
Tech stocks are now cheaper than the S&P 500 for the first time since 2017 — here's what history says comes next: Chart of the Day
Bloomberg
·
21 сағат бұрын
Wall Street Strategists Call Stock Rout a Fresh Reason to Buy
AP News
·
1 күн бұрын
Carney welcomes Democrats’ push to end Trump’s tariffs on Canada after midterm victory
Investor's Business Daily
·
7 сағат бұрын
Dow Jones Futures: Market Damaged, Big Winners Broken; Apple, Amazon, Microsoft Strong
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com